AVODART® Alopecia Post-marketing Surveillance (PMS)

• Status: Completed
• Trial end date: 2012-12-21
• Target enrollment: 0
• Participant gender: Male

Summary

Post-marketing surveillance(PMS) to monitor the safety and effectiveness of dutasteride in Korean androgenetic alopecia patients

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Dutasteride

Criteria

Inclusion Criteria:

• Men (18-41 years of age) with male pattern hair loss (androgenetic alopecia)

• Subjects with no experience of treatment using dutasteride

• Subjects who the investigator believes that they can and will comply with the requirements of the protocol

• Subjects who prescribed with dutasteride according to the Prescribing Information

Exclusion Criteria:

• Considering the nature of observational study, GSK Korea encourages the doctors participating in this study to enrol the subjects prescribed with dutasteride following the locally approved Prescribing Information. Subject who give informed consent is enrolled. However, if institution waives the requirement for informed consent, informed consent is not required. In this case, monitoring does not proceed.